Search

Knowledge about how and where proteins interact provides a pillar for cell biology. Protein proximity-labeling has emerged as an important tool to detect protein interactions. Biotin-related proximity labeling approaches are by far the most commonly used but may have labeling-related drawbacks. Here, we use pupylation-based proximity labeling (PUP-IT) as a tool for protein interaction detection in plants. We show that PUP-IT readily confirmed protein interactions for several known protein complexes across different types of plant hosts and that the approach increased detection of specific interactions as compared to biotin-based proximity labeling systems. To further demonstrate the power of PUP-IT, we used the system to identify protein interactions of the protein complex that underpin cellulose synthesis in plants. Apart from known complex components, we identified the ARF-GEF BEN1 (BFA-VISUALIZED ENDOCYTIC TRAFFICKING DEFECTIVE1). We show that BEN1 contributes to cellulose synthesis by regulating both clathrin-dependent and -independent endocytosis of the cellulose synthesis protein complex from the plasma membrane. Our results highlight PUP-IT as a powerful proximity labeling system to identify protein interactions in plant cells., Competing Interests: Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)

Background: Central retinal vein occlusion and cilioretinal artery occlusion are rare but serious ocular conditions that can lead to significant visual impairment. While few cases of central retinal vein occlusion and cilioretinal artery occlusion have been individually reported, concurrent occlusion of both vessels is extremely rare, particularly in younger patients without traditional vascular risk factors. We present the first reported case of simultaneous central retinal vein occlusion and cilioretinal artery occlusion in a young female patient associated with short-term use of progestin-only oral contraceptives (OCPs)., Case Presentation: A 28-year-old Pakistani female patient presented with sudden, painless vision loss in the left eye, 3 hours prior to her arrival at the ophthalmology clinic. Visual acuity in the affected eye was limited to counting fingers at a distance of 0.5 feet, with a best-corrected visual acuity of 6/6 in the right eye. Fundoscopic examination revealed optic disc edema, preretinal hemorrhages, venous dilation, and cotton wool spots consistent with central retinal vein occlusion, alongside ischemic changes in the foveal region suggestive of cilioretinal artery occlusion. On the basis of clinical examination, fundus fluorescein angiography, and optical coherence tomography findings, the patient was diagnosed with concurrent central retinal vein occlusion and cilioretinal artery occlusion. Systemic workup to rule out thrombophilia and other vascular risks was negative. She was treated with acetazolamide, aspirin, and ocular massage, alongside a dorzolamide-timolol combination for intraocular pressure control. Six weeks later, panretinal photocoagulation was performed to prevent neovascular complications., Conclusions: This case highlights the rare presentation of simultaneous central retinal vein occlusion and cilioretinal artery occlusion, likely precipitated by short-term progestin-only OCP use in a young female. The absence of other vascular risk factors emphasizes the potential thrombotic risk associated with hormonal contraception, even in brief courses. Careful consideration should be given to contraceptive choice, and ophthalmologic monitoring is recommended for early detection and intervention in at-risk patients., Competing Interests: Declarations. Ethics approval and consent to participate: No ethical approval was required to report this case; however, consent was given by the patient before writing the case report. Consent for publication: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests: The authors have no conflicts of interest to declare., (© 2025. The Author(s).)